LV-Visio-AMTRIX
- Generic Name
- LV-Visio-AMTRIX
Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis
- First Posted Date
- 2022-02-22
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- TBF Genie Tissulaire
- Target Recruit Count
- 5
- Registration Number
- NCT05250583
- Locations
- 🇫🇷
CHU de Saint-Etienne Hôpital Nord, Saint-Priest-en-Jarez, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath